What is the HPV Virus?

Human Papillomavirus (HPV) is a very common group of viruses, with over 100 different types. About 30 of these types infect the human genital area1.

High-risk HPV: Approximately 17 types are classified as high-risk (most commonly types 16 and 18). They are the primary cause of cervical cancer. Persistent infection with high-risk HPV can lead to abnormal cervical cells, which may develop into cancer.
Low-risk HPV: Mainly causes genital warts (commonly known as cauliflower-like warts) but does not develop into cancer.

Important Facts: HPV infection is extremely common; up to 80% of sexually active men and women will be infected at some point in their lives2. Usually, the infection clears on its own within a short period. However, persistent infection with high-risk HPV can lead to pre-cancerous lesions and cancer. The medical community has confirmed that the vast majority of cervical cancer cases (90-91%) are caused by persistent HPV infection. Compared to low-risk HPV, persistent infection with high-risk HPV increases the chance of developing cervical cancer by at least 30 times3. Therefore, understanding the carcinogenic causes is essential for preventing cervical cancer.

Risk Factors for Cervical Cancer?4

Persistent infection with high-risk HPV: This is the most significant risk factor
Early sexual activity: The younger the age at first sexual intercourse, the higher the relative chance of HPV infection
Multiple sexual partners: Having more sexual partners increases the chance of infection with high-risk HPV
Weakened immune system: For example, individuals with HIV or those taking anti-rejection medication after organ transplants find it harder for their immune to clear HPV
Smoking: Smoking weakens local immunity, increasing the risk of persistent infection and cancerous changes
Long-term use of oral contraceptives: Long-term use may slightly increase the risk
Multiple pregnancies: Women who have given birth to many children may have a higher risk

Symptoms of Cervical Cancer?5

Early-stage cervical cancer or pre-cancerous lesions often have no obvious symptoms, making regular testing crucial

When the condition progresses to mid or late stages, the following symptoms may occur:

Abnormal vaginal bleeding: For example, bleeding between periods, after sexual intercourse, or after menopause
Abnormal vaginal discharge: Changes in the color, odor, or texture of discharge, which may be bloody or foul-smelling
Pelvic pain or pain during sexual intercourse
If the cancer has spread, symptoms like back pain, leg swelling, or difficulty urinating may occur

Note: Experiencing these symptoms does not necessarily mean you have cancer, but you must seek medical attention immediately to determine the cause.

Testing Methods: Traditional Pap Smear vs. HPV Virus DNA Urine Test

Testing Item HPV Virus DNA Urine Test (PanHPV DNA Urine Test) Traditional Pap Smear Test (Pap Smear)
Sampling Method Non-invasive: Only requires collecting first-void urine Invasive: Uses a brush or spatula to scrape cell samples from the cervix
Testing Target Directly tests for the presence of high-risk HPV virus DNA (the root cause of cancer) and low-risk HPV (mainly causing genital warts) in the urine Primarily detects abnormal cervical cells
Advantages
    Painless, non-invasive, no embarrassment
    Highly private
    Convenient and time-saving
    Can detect the risk of viral infection earlier
    Long-standing widespread use, mature technology
    Effective at detecting already abnormal cells
Suitable For Especially suitable for those afraid of internal examination, busy with work, or preferring a more private method for preliminary screening. Both men and women Suitable for all sexually experienced women as a routine check-up. For women only

Why Choose This Test?

Ultimate Privacy and Dignity

Completely avoids the physical and psychological discomfort of internal examinations, protecting personal privacy

Painless, Non-invasive, Safe & Simple

The entire process is painless, very suitable for women who fear internal examinations

Unprecedented Convenience

Self-sampling completed in just ten minutes, easily integrated into a busy life

Scientific Accuracy, Prevention is Key

Uses PCR molecular testing technology to directly detect the DNA of the cancer-causing virus, allowing for early risk detection before cell changes occur, seizing the best opportunity for prevention

Testing Capability

Testing Technology

Real-time Polymerase Chain Reaction (Real-time PCR) technology

Detection Typing

Can detect a total of 24 HPV virus types (including high-risk types 16, 18, 31, 33, 45, 52, 58, 35, 39, 51, 53, 56, 59, 66, 68, 73, 82 and low-risk types 6, 11, 26, 42, 43, 44, and 81)

Accuracy

Clinical studies show that the test's overall sensitivity and specificity both exceed 90%, making it a highly effective primary screening tool

Test Details

Code Testing Method Sample Requirement Turnaround Time
IHU Real-time Polymerase Chain Reaction (Real-time PCR) Technology 20ml using the DiagCor Urine Self-Collection Kit* 2 working days

*Click here to watch the Pangenia PanHPV / PanSTD Urine Sample Collection Tutorial

Sample Requirements and Handling Instructions

Type Pre-sampling Preparation Sampling Requirements
Urine It is recommended that the patient does not urinate for at least two hours prior to sample collection Collect 20 ml of first-void urine using the DiagCor Urine Self-Collection Kit

References

  1. 1 https://www.hksccp.org.hk/index2.php?title=3&page=1#q7
  2. 2 https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer
  3. 3 http://globocan.iarc.fr/old/FactSheets/cancers/cervix-new.asp
  4. 4 https://www.cancer.org/cancer/types/cervical-cancer/causes-risks-prevention/risk-factors.html
  5. 5 https://www.cancercarers.org.hk/%E7%99%8C%E7%97%87%E7%A8%AE%E9%A1%9E/%E5%AD%90%E5%AE%AE%E9%A0%B8%E7%99%8C